Humanwell Healthcare Subsidiary Completes Stake Sale in Lefusi Health Industry

MT Newswires Live

Sep 07

Humanwell Healthcare (SHA:600079) completed the sale of its 16.34% stake in Lefusi Health Industry held by its subsidiary RFSW Holding, to Wuhan Hairun Biotechnology, according to a Saturday filing with the Shanghai bourse.

The pharmaceutical company received the full payment of 955.4 million yuan, net of taxes and stamp duties, from the sale of 81.7 million shares.

The shares were sold via public bidding on the Beijing Equity Exchange, the pharmaceutical company said in its filing.

Humanwell expects the transaction to positively impact its bottom line by 500 million yuan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2665192399"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2665192399\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2665192399?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-07 12:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2665192399","market":"us","top_or_hot":-1,"title":"Humanwell Healthcare Subsidiary Completes Stake Sale in Lefusi Health Industry","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/600079\">Humanwell Healthcare</a> (SHA:600079) completed the sale of its 16.34% stake in Lefusi Health Industry held by its subsidiary RFSW Holding, to Wuhan Hairun Biotechnology, according to a Saturday filing with the Shanghai bourse.</p><p>The pharmaceutical company received the full payment of 955.4 million yuan, net of taxes and stamp duties, from the sale of 81.7 million shares.</p><p>The shares were sold via public bidding on the Beijing Equity Exchange, the pharmaceutical company said in its filing.</p><p>Humanwell expects the transaction to positively impact its bottom line by 500 million yuan.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Humanwell Healthcare Subsidiary Completes Stake Sale in Lefusi Health Industry</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHumanwell Healthcare Subsidiary Completes Stake Sale in Lefusi Health Industry\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-07 12:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/600079\">Humanwell Healthcare</a> (SHA:600079) completed the sale of its 16.34% stake in Lefusi Health Industry held by its subsidiary RFSW Holding, to Wuhan Hairun Biotechnology, according to a Saturday filing with the Shanghai bourse.</p><p>The pharmaceutical company received the full payment of 955.4 million yuan, net of taxes and stamp duties, from the sale of 81.7 million shares.</p><p>The shares were sold via public bidding on the Beijing Equity Exchange, the pharmaceutical company said in its filing.</p><p>Humanwell expects the transaction to positively impact its bottom line by 500 million yuan.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LABU","symbol_name":"三倍做多标普生物-Direxion","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2665192399","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2665192399","pubTimestamp":1788756827,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Humanwell Healthcare  completed the sale of its 16.34% stake in Lefusi Health Industry held by its subsidiary RFSW Holding, to Wuhan Hairun Biotechnology, according to a Saturday filing with the Shanghai bourse.The pharmaceutical company received the full payment of 955.4 million yuan, net of taxes and stamp duties, from the sale of 81.7 million shares.The shares were sold via public bidding on the Beijing Equity Exchange, the pharmaceutical company said in its filing.Humanwell expects the transaction to positively impact its bottom line by 500 million yuan.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600079":"ST人福","LABU":"三倍做多标普生物-Direxion","XBI":"SPDR S&P Biotech ETF","HCSG":"Healthcare Svcs Group Inc","BK0028":"国家队","BK0185":"二线龙头","BK0239":"医药制造","BK4137":"综合支持服务","XLV":"健康照护类股ETF-SPDR","BK4588":"碎股","BK0096":"民营医院","BK0070":"员工持股","BK0188":"融资融券","BK4585":"ETF&股票定投概念","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK0012":"证金概念","BK4581":"高盛持仓","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC"},"translate_title":"人福医疗子公司完成乐福思健康产业股权出售","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600079":0.9,"LABU":0.6,"XBI":0.6,"HCSG":1.5,"XLV":1.5},"content_text":"Humanwell Healthcare (SHA:600079) completed the sale of its 16.34% stake in Lefusi Health Industry held by its subsidiary RFSW Holding, to Wuhan Hairun Biotechnology, according to a Saturday filing with the Shanghai bourse.The pharmaceutical company received the full payment of 955.4 million yuan, net of taxes and stamp duties, from the sale of 81.7 million shares.The shares were sold via public bidding on the Beijing Equity Exchange, the pharmaceutical company said in its filing.Humanwell expects the transaction to positively impact its bottom line by 500 million yuan.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}